GlassScriptPhysician profile
Carla I Bourne
NPI 1073707840
$27,173.76
in general payments reported to CMS, 2019-2025
15 companies · $764 in 2025
The $764 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,125 · 2020: $1,948 · 2021: $12K · 2022: $983 · 2023: $3,939 · 2024: $1,260 · 2025: $764.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,195 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,000 · Consulting Fee: $550 · Entertainment: $218.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,195.16 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,000.00 |
| Consulting Fee | $550.00 |
| Entertainment | $218.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $16,618.77 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Allergan, INC. | $6,455.49 | 2019-2022 | |
| Abbvie INC. | $1,904.02 | 2022-2025 | Durysta, Lumigan, Xen Glaucoma Treatment System |
| New World Medical,INC. | $760.90 | 2019-2025 | Ahmed Glaucoma Valve, Kahook Dual Blade, Via360 |
| Nova Eye, INC. | $340.75 | 2024-2025 | |
| Aerie Pharmaceuticals, INC. | $230.94 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $197.10 | 2021-2024 | |
| Alcon Vision LLC | $150.00 | 2023 | Rocklatan |
| Genentech USA, INC. | $147.81 | 2024 | Susvimo, Vabysmo |
| Ivantis, INC | $116.35 | 2021 | |
| Iridex Corporation | $65.15 | 2021 | |
| Harrow Eye, LLC | $59.14 | 2024 | Vevye |
| Tarsus Pharmaceuticals, INC. | $59.03 | 2024 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $45.46 | 2022 | |
| Oyster Point Pharma, INC. | $22.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carla Bourne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.